15013589

Source:http://linkedlifedata.com/resource/pubmed/id/15013589

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:15013589	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:15013589	lifeskim:mentions	umls-concept:C0006826	lld:lifeskim
pubmed-article:15013589	lifeskim:mentions	umls-concept:C0817096	lld:lifeskim
pubmed-article:15013589	lifeskim:mentions	umls-concept:C0146224	lld:lifeskim
pubmed-article:15013589	lifeskim:mentions	umls-concept:C0034541	lld:lifeskim
pubmed-article:15013589	lifeskim:mentions	umls-concept:C0920321	lld:lifeskim
pubmed-article:15013589	pubmed:issue	1	lld:pubmed
pubmed-article:15013589	pubmed:dateCreated	2004-3-11	lld:pubmed
pubmed-article:15013589	pubmed:abstractText	To determine the maximum-tolerated dose (MTD) of daily Topotecan with full-dose thoracic radiotherapy (XRT).	lld:pubmed
pubmed-article:15013589	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15013589	pubmed:language	eng	lld:pubmed
pubmed-article:15013589	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15013589	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:15013589	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15013589	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15013589	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15013589	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:15013589	pubmed:month	Apr	lld:pubmed
pubmed-article:15013589	pubmed:issn	0169-5002	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:BerlinJordanJ	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:WildingGeorge...	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:StorerBarryB	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:MehtaMineshM	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:SchillerJoanJ	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:ForouzanniaAf...	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:HutsonPaulP	lld:pubmed
pubmed-article:15013589	pubmed:author	pubmed-author:BoothmanDavid...	lld:pubmed
pubmed-article:15013589	pubmed:issnType	Print	lld:pubmed
pubmed-article:15013589	pubmed:volume	44	lld:pubmed
pubmed-article:15013589	pubmed:owner	NLM	lld:pubmed
pubmed-article:15013589	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:15013589	pubmed:pagination	111-9	lld:pubmed
pubmed-article:15013589	pubmed:dateRevised	2007-11-14	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:meshHeading	pubmed-meshheading:15013589...	lld:pubmed
pubmed-article:15013589	pubmed:year	2004	lld:pubmed
pubmed-article:15013589	pubmed:articleTitle	A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies.	lld:pubmed
pubmed-article:15013589	pubmed:affiliation	Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison, WI 53792, USA.	lld:pubmed
pubmed-article:15013589	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:15013589	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:15013589	pubmed:publicationType	Research Support, U.S. Gov't, P.H.S.	lld:pubmed
pubmed-article:15013589	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed